Studies on Novel Pyridine and 2-pyridone Derivatives of N-arylpiperazine as -adrenoceptor Ligands

By  

Medicinal Chemistry, Vol. 10, Iss. 2, 2014-03 ,pp. : 144-153

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine D2 Receptor-Mediated Inhibition of Dopaminergic Neurons in Mice Lacking D2L Receptors

By Centonze D.   Usiello A.   Gubellini P.   Pisani A.   Borrelli E.   Bernardi G.   Calabresi P.  

Neuropsychopharmacology, Vol. 27, Iss. 5, 2002-11 ,pp. : 723-726

Elsevier

Access to resources Recommend Favorite

Receptor-Binding and Pharmacokinetic Properties of Dopaminergic Agonists

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 12, 2008-08 ,pp. : 1049-1067

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor ligands attenuate N-methyl-d-aspartate cytotoxicity in dopaminergic neurons of mesencephalic slice cultures

By Shimazu S.   Katsuki H.   Takenaka C.   Tomita M.   Kume T.   Kaneko S.   Akaike A.  

European Journal of Pharmacology, Vol. 388, Iss. 2, 2000-01 ,pp. : 139-146

Elsevier

Access to resources Recommend Favorite

No association of the dopamine D2 receptor A1 allele with clinical and neurobiological phenotypes related to dopaminergic functions in alcoholism

By Schmidt L.G.   Harms H.   Sander T.   Rommelspacher H.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 395-396

Elsevier

Access to resources Recommend Favorite